NCT04925765

Brief Summary

The purpose of this study is to test patient feasibility and acceptability of virtual reality biofeedback program in postpartum women for anxiety and depression outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 14, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2021

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

April 17, 2024

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

29 days

First QC Date

June 7, 2021

Results QC Date

September 28, 2022

Last Update Submit

April 9, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Intervention Feasibility

    Patient response to the feasibility of VR use. The question asked was, "I was able to do the session without difficulty," which was measured on a Likert Scale of 1-5. A score of 1 is indicative of great difficulty present and a score of 5 is indicative of no difficulty present. Outcome measurement is presented as an averaged score with standard deviation among participating patients.

    Completed immediately after the VR session.

  • Intervention Acceptability

    Acceptability was assessed by questions, "Would you participate in another session?" Acceptability was measured by yes/no responses and reported as an overall percentage of participating patients who responded as yes.

    Completed directly after the VR intervention session and anxiety/depression measurements.

Secondary Outcomes (2)

  • Decrease in Depression From Baseline to Post-intervention

    EPDS Completed directly before and after VR session.

  • Decrease in State-Trait Anxiety Inventory (STAI) From Baseline to Post-intervention

    Completed directly before and after VR session.

Study Arms (1)

Virtual Reality (VR) Session

EXPERIMENTAL

All participants in this study will complete a 1 hour virtual reality session.

Other: Virtual Reality Biofeedback Session

Interventions

The "Flowly" intervention treatment utilizes virtual reality and biofeedback to train patients to auto-regulate themselves and improve their pain/anxiety/depression.

Virtual Reality (VR) Session

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently pregnant or postpartum (delivery within 3 months)
  • years or older

You may not qualify if:

  • Unable to participate in study procedures
  • English illiterate (surveys validated in English)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (8)

  • Stamou G, Garcia-Palacios A, Botella C. Cognitive-Behavioural therapy and interpersonal psychotherapy for the treatment of post-natal depression: a narrative review. BMC Psychol. 2018 Jun 18;6(1):28. doi: 10.1186/s40359-018-0240-5.

    PMID: 29914574BACKGROUND
  • Kolbe L, Jaywant A, Gupta A, Vanderlind WM, Jabbour G. Use of virtual reality in the inpatient rehabilitation of COVID-19 patients. Gen Hosp Psychiatry. 2021 Jul-Aug;71:76-81. doi: 10.1016/j.genhosppsych.2021.04.008. Epub 2021 Apr 29.

    PMID: 33964789BACKGROUND
  • Baschong A, Spiess F, Cattin PC, Navarini A, Mueller SM. Itch reduction using immersive virtual reality-An experimental pilot study. Dermatol Ther. 2021 Jul;34(4):e15001. doi: 10.1111/dth.15001. Epub 2021 Jun 9.

    PMID: 34036696BACKGROUND
  • Vlake JH, Van Bommel J, Wils EJ, Korevaar TIM, Hellemons ME, Schut AFC, Labout JAM, Schreuder LLH, Gommers D, Van Genderen ME. Effect of intensive care unit-specific virtual reality (ICU-VR) to improve psychological well-being and quality of life in COVID-19 ICU survivors: a study protocol for a multicentre, randomized controlled trial. Trials. 2021 May 5;22(1):328. doi: 10.1186/s13063-021-05271-z.

    PMID: 33952318BACKGROUND
  • Sasseville M, LeBlanc A, Boucher M, Dugas M, Mbemba G, Tchuente J, Chouinard MC, Beaulieu M, Beaudet N, Skidmore B, Cholette P, Aspiros C, Larouche A, Chabot G, Gagnon MP. Digital health interventions for the management of mental health in people with chronic diseases: a rapid review. BMJ Open. 2021 Apr 5;11(4):e044437. doi: 10.1136/bmjopen-2020-044437.

    PMID: 33820786BACKGROUND
  • Alneyadi M, Drissi N, Almeqbaali M, Ouhbi S. Biofeedback-Based Connected Mental Health Interventions for Anxiety: Systematic Literature Review. JMIR Mhealth Uhealth. 2021 Apr 22;9(4):e26038. doi: 10.2196/26038.

    PMID: 33792548BACKGROUND
  • Polat M, Kahveci A, Muci B, Gunendi Z, Kaymak Karatas G. The Effect of Virtual Reality Exercises on Pain, Functionality, Cardiopulmonary Capacity, and Quality of Life in Fibromyalgia Syndrome: A Randomized Controlled Study. Games Health J. 2021 Jun;10(3):165-173. doi: 10.1089/g4h.2020.0162. Epub 2021 Mar 9.

    PMID: 33689452BACKGROUND
  • Turrado V, Guzman Y, Jimenez-Lillo J, Villegas E, de Lacy FB, Blanch J, Balibrea JM, Lacy A. Exposure to virtual reality as a tool to reduce peri-operative anxiety in patients undergoing colorectal cancer surgery: a single-center prospective randomized clinical trial. Surg Endosc. 2021 Jul;35(7):4042-4047. doi: 10.1007/s00464-021-08407-z. Epub 2021 Mar 8.

    PMID: 33683433BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersDepressionDepression, Postpartum

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorPuerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood Disorders

Limitations and Caveats

The study is limited by the exploratory nature and small sample size, but feasibility is appropriate to assess in a clinical setting.

Results Point of Contact

Title
Dr. Katherine Grace Lim
Organization
University of Pittsburgh Medical Center

Study Officials

  • Grace Lim, MD,MS

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 7, 2021

First Posted

June 14, 2021

Study Start

September 1, 2021

Primary Completion

September 30, 2021

Study Completion

October 15, 2021

Last Updated

April 17, 2024

Results First Posted

April 17, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations